Vor Biopharma Inc.VORNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +1.27% | +1.20% | +83.48% | +83.42% | +95.19% |
| Weighted Average Shares Diluted Growth | +1.27% | +1.20% | +83.48% | +83.42% | +95.19% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -47.99% | -31.90% | -34.56% | +45.05% | +51.94% |
| Book Value per Share Growth | -58.78% | -36.63% | -70.73% | +0.00% | +0.00% |
| Debt Growth | -10.23% | -10.74% | -11.39% | -100.00% | -90.69% |
| R&D Expense Growth | -20.97% | +21.30% | +9.78% | +1098.27% | -35.18% |
| SG&A Expenses Growth | -13.15% | -19.53% | -6.67% | -62.02% | +115.29% |